Heba Elsayed Abd Elhaliam Baioumy
Lecturer
Role of IRE1 /XBP1/CHOP/NLRP3 Signalling Pathway in Neonicotinoid Imidacloprid-Induced Pancreatic Dysfunction in Rats and Antagonism of Lycopene: In Vivo and Molecular Docking Simulation Approaches
• 2024
Publication Information
Authors
Walaa Bayoumie El Gazzar 1,2, Heba Bayoumi 3, Heba S. Youssef
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Imidacloprid (IMI) is a commonly used new-generation pesticide that has numerous harmful
effects on non-targeted organisms, including animals. This study analysed both the adverse
effects on the pancreas following oral consumption of imidacloprid neonicotinoids (45 mg/kg daily
for 30 days) and the potential protective effects of lycopene (LYC) administration (10 mg/kg/day
for 30 days) with IMI exposure in male Sprague–Dawley rats. The apoptotic, pyroptotic, inflammatory,
oxidative stress, and endoplasmic reticulum stress biomarkers were evaluated, along with
the histopathological alterations. Upon IMI administration, noticeable changes were observed in
pancreatic histopathology. Additionally, elevated oxidative/endoplasmic reticulum-associated stress
biomarkers, inflammatory, pyroptotic, and apoptotic biomarkers were also observed following IMI
administration. LYC effectively reversed these alterations by reducing oxidative stress markers (e.g.,
MDA) and enhancing antioxidant enzymes (SOD, CAT). It downregulated ER stress markers (IRE1 ,
XBP1, CHOP), decreased pro-inflammatory cytokines (TNF- , IL-1 ), and suppressed pyroptotic
(NLRP3, caspase-1) along with apoptotic markers (Bax, cleaved caspase-3). It also improved the
histopathological and ultrastructure alterations brought on by IMI toxicity.
effects on non-targeted organisms, including animals. This study analysed both the adverse
effects on the pancreas following oral consumption of imidacloprid neonicotinoids (45 mg/kg daily
for 30 days) and the potential protective effects of lycopene (LYC) administration (10 mg/kg/day
for 30 days) with IMI exposure in male Sprague–Dawley rats. The apoptotic, pyroptotic, inflammatory,
oxidative stress, and endoplasmic reticulum stress biomarkers were evaluated, along with
the histopathological alterations. Upon IMI administration, noticeable changes were observed in
pancreatic histopathology. Additionally, elevated oxidative/endoplasmic reticulum-associated stress
biomarkers, inflammatory, pyroptotic, and apoptotic biomarkers were also observed following IMI
administration. LYC effectively reversed these alterations by reducing oxidative stress markers (e.g.,
MDA) and enhancing antioxidant enzymes (SOD, CAT). It downregulated ER stress markers (IRE1 ,
XBP1, CHOP), decreased pro-inflammatory cytokines (TNF- , IL-1 ), and suppressed pyroptotic
(NLRP3, caspase-1) along with apoptotic markers (Bax, cleaved caspase-3). It also improved the
histopathological and ultrastructure alterations brought on by IMI toxicity.